The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans
- PMID: 10696568
- DOI: 10.1210/edrv.21.1.0387
The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans
Abstract
Achondroplasia, the most common form of short-limbed dwarfism in humans, occurs between 1 in 15,000 and 40,000 live births. More than 90% of cases are sporadic and there is, on average, an increased paternal age at the time of conception of affected individuals. More then 97% of persons with achondroplasia have a Gly380Arg mutation in the transmembrane domain of the fibroblast growth factor receptor (FGFR) 3 gene. Mutations in the FGFR3 gene also result in hypochondroplasia, the lethal thanatophoric dysplasias, the recently described SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans) dysplasia, and two craniosynostosis disorders: Muenke coronal craniosynostosis and Crouzon syndrome with acanthosis nigricans. Recent evidence suggests that the phenotypic differences may be due to specific alleles with varying degrees of ligand-independent activation, allowing the receptor to be constitutively active. Since the Gly380Arg achondroplasia mutation was recognized, similar observations regarding the conserved nature of FGFR mutations and resulting phenotype have been made regarding other skeletal phenotypes, including hypochondroplasia, thanatophoric dysplasia, and Muenke coronal craniosynostosis. These specific genotype-phenotype correlations in the FGFR disorders seem to be unprecedented in the study of human disease. The explanation for this high degree of mutability at specific bases remains an intriguing question.
Similar articles
-
Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.Nat Genet. 1995 Dec;11(4):462-4. doi: 10.1038/ng1295-462. Nat Genet. 1995. PMID: 7493034
-
Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.Am J Med Genet. 2001 Jan 1;98(1):75-91. Am J Med Genet. 2001. PMID: 11426459
-
Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.Am J Med Genet A. 2017 Apr;173(4):1097-1101. doi: 10.1002/ajmg.a.38141. Epub 2017 Feb 9. Am J Med Genet A. 2017. PMID: 28181399
-
Hearing loss in syndromic craniosynostoses: otologic manifestations and clinical findings.Int J Pediatr Otorhinolaryngol. 2014 Dec;78(12):2037-47. doi: 10.1016/j.ijporl.2014.09.019. Epub 2014 Sep 28. Int J Pediatr Otorhinolaryngol. 2014. PMID: 25441602 Review.
-
Short-limb skeletal dysplasias and craniosynostosis: what do they have in common?Pediatr Radiol. 1997 May;27(5):442-6. doi: 10.1007/s002470050165. Pediatr Radiol. 1997. PMID: 9133360 Review.
Cited by
-
Atypical presentation of acanthosis nigricans.Indian J Endocrinol Metab. 2012 Nov;16(6):1058-9. doi: 10.4103/2230-8210.103048. Indian J Endocrinol Metab. 2012. PMID: 23226673 Free PMC article. No abstract available.
-
Muenke syndrome.Childs Nerv Syst. 2004 May;20(5):297-301. doi: 10.1007/s00381-003-0906-y. Epub 2004 Feb 10. Childs Nerv Syst. 2004. PMID: 14963686
-
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13450-4. doi: 10.1073/pnas.0705218104. Epub 2007 Aug 2. Proc Natl Acad Sci U S A. 2007. PMID: 17673550 Free PMC article.
-
Expression of FGFR-2 and FGFR-3 in the normal human fetal orbit.Br J Ophthalmol. 2005 Dec;89(12):1643-5. doi: 10.1136/bjo.2005.075978. Br J Ophthalmol. 2005. PMID: 16299148 Free PMC article.
-
Growth charts in FGFR2- and FGFR3-related faciocraniosynostoses.Bone Rep. 2022 Mar 26;16:101524. doi: 10.1016/j.bonr.2022.101524. eCollection 2022 Jun. Bone Rep. 2022. PMID: 35372644 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases